BRIM Biotechnology, Inc. engages in the research and development of treatment drugs. It offers medicines for dry eye syndrome, corneal damage repair, neurotrophic keratitis, and osteoarthritis. The company was founded by Hai Shan Jian and Wen Chi Lee on July 31, 2013 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company